Teruaki Masuda

1.2k total citations
80 papers, 656 citations indexed

About

Teruaki Masuda is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Teruaki Masuda has authored 80 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 21 papers in Neurology and 19 papers in Physiology. Recurrent topics in Teruaki Masuda's work include Amyloidosis: Diagnosis, Treatment, Outcomes (37 papers), Alzheimer's disease research and treatments (15 papers) and Parathyroid Disorders and Treatments (11 papers). Teruaki Masuda is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (37 papers), Alzheimer's disease research and treatments (15 papers) and Parathyroid Disorders and Treatments (11 papers). Teruaki Masuda collaborates with scholars based in Japan, United States and India. Teruaki Masuda's co-authors include Yukio Ando, Mitsuharu Ueda, Yohei Misumi, Taro Yamashita, Yasuteru Inoue, Masayoshi Tasaki, Konen Obayashi, Noriyuki Kimura, Toshiya Nomura and Toshihide Kumamoto and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Diabetes.

In The Last Decade

Teruaki Masuda

74 papers receiving 647 citations

Peers

Countries citing papers authored by Teruaki Masuda

Since Specialization

Citations

This map shows the geographic impact of Teruaki Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruaki Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruaki Masuda more than expected).

Fields of papers citing papers by Teruaki Masuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teruaki Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruaki Masuda. The network helps show where Teruaki Masuda may publish in the future.

Co-authorship network of co-authors of Teruaki Masuda

This figure shows the co-authorship network connecting the top 25 collaborators of Teruaki Masuda. A scholar is included among the top collaborators of Teruaki Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teruaki Masuda. Teruaki Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment 2025 ·Journal of Alzheimer s Disease ·(unknown), Noriyuki Kimura, (unknown), Teruaki Masuda, (unknown), Etsuro Matsubara	0
2	X-linked Myotubular Myopathy Manifesting Carrier with Central and Peripheral Nervous System Involvement 2024 ·Internal Medicine ·(unknown), Teruaki Masuda, Noriyuki Kimura, (unknown), Mika Jikumaru, Nobuyuki Eura, Ichizo Nishino, Etsuro Matsubara	1
3	Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis 2023 ·Muscle & Nerve ·Teruaki Masuda, Yohei Misumi, Toshiya Nomura, (unknown), Masayoshi Tasaki, Konen Obayashi, Yukio Ando, Mitsuharu Ueda	0
4	α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation 2022 ·Cellular and Molecular Life Sciences ·Yasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Toshiya Nomura, Yukio Ando, Mitsuharu Ueda	2
5	Glavonoid, a possible supplement for prevention of ATTR amyloidosis 2021 ·Heliyon ·Hiroaki Matsushita, (unknown), (unknown), Teruaki Masuda, Yohei Misumi, (unknown), (unknown), (unknown), Jinko Sawashita, Mitsuharu Ueda, Mineyuki Mizuguchi, Yukio Ando	7
6	Clinical, pathological, and proteomic characteristics of newly diagnosed amyloidosis patients: Experience from a single referral center in Japan 2020 ·Neurology and Clinical Neuroscience ·Yukio Ando, Taro Yamashita, Yohei Misumi, Toshiya Nomura, (unknown), (unknown), Yasuteru Inoue, Teruaki Masuda, Mitsuharu Ueda, (unknown), Konen Obayashi, Hirotaka Matsui, Hironobu Naiki	2
7	Plasma Growth Differentiation Factor 15: A Novel Tool to Detect Early Changes of Hereditary Transthyretin Amyloidosis 2020 ·ESC Heart Failure ·(unknown), Yohei Misumi, Teruaki Masuda, (unknown), Masayoshi Tasaki, Hiroaki Matsushita, Mitsuharu Ueda, Yasuteru Inoue, Toshiya Nomura, Makoto Nakajima, Taro Yamashita, Satoru Shinriki, Hirotaka Matsui, Kenichi Tsujita, Yukio Ando	6
8	Novel dot-blot assay for detection of vascular Notch3 aggregates in patients with CADASIL 2020 ·Journal of the Neurological Sciences ·Yihong Ma, Mitsuharu Ueda, Satoru Shinriki, (unknown), (unknown), (unknown), Masayoshi Tasaki, Toshiya Nomura, Yasuteru Inoue, Teruaki Masuda, Yohei Misumi, Taro Yamashita, Hirotaka Matsui, Yukio Ando	5
9	A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH 2019 ·Journal of Biological Chemistry ·Mitsuharu Ueda, (unknown), Mineyuki Mizuguchi, Barbara Kluve‐Beckerman, (unknown), (unknown), Yohei Misumi, Masayoshi Tasaki, Akinori Kanai, (unknown), Teruaki Masuda, Yasuteru Inoue, Toshiya Nomura, Satoru Shinriki, Tsuyoshi Shuto, Hirofumi Kai, Taro Yamashita, Hirotaka Matsui, Merrill D. Benson, Yukio Ando	16
10	New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis 2019 ·Orphanet Journal of Rare Diseases ·Toshiya Nomura, Mitsuharu Ueda, Masayoshi Tasaki, Yohei Misumi, Teruaki Masuda, Yasuteru Inoue, (unknown), (unknown), Takahiro Okazaki, (unknown), (unknown), Makoto Nakamura, Konen Obayashi, Satoru Shinriki, Hirotaka Matsui, Taro Yamashita, Yukio Ando	5
11	Memantine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression 2019 ·Molecular Neurobiology ·Yasuteru Inoue, Mitsuharu Ueda, Teruaki Masuda, Yohei Misumi, Taro Yamashita, Yukio Ando	20
12	Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL 2017 ·Journal of the Neurological Sciences ·(unknown), Mitsuharu Ueda, Masayoshi Tasaki, Yasuteru Inoue, Yihong Ma, Teruaki Masuda, (unknown), Sayaka Matsumoto, Takayuki Kosaka, Takayuki Kawano, Takaaki Ito, Yukio Ando	10
13	Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin 2017 ·Scientific Reports ·(unknown), Tokunori Ikeda, Teruaki Masuda, (unknown), Taro Yamashita, (unknown), Yohei Misumi, Mitsuharu Ueda, Hirotaka Matsui, Satoru Senju, Yukio Ando	13
14	[O3–08–02]: MEMANTINE ATTENUATES VASCULAR AMYLOID β DEPOSITS AND SPONTANEOUS HEMORRHAGES IN MOUSE MODELS OF CEREBRAL AMYLOID ANGIOPATHY 2017 ·Alzheimer s & Dementia ·Yasuteru Inoue, Mitsuharu Ueda, Teruaki Masuda, Yohei Misumi, Taro Yamashita, Yukio Ando	1
15	MLC1 mutations in Japanese patients with megalencephalic leukoencephalopathy with subcortical cysts 2014 ·Human Genome Variation ·Shino Shimada, Keiko Shimojima, Teruaki Masuda, (unknown), (unknown), Hiroko Tsukamoto, (unknown), Akira Oka, Toshiyuki Yamamoto	4
16	A case of limbic encephalitis repeated aphasic status epilepticus with periodic lateralized epileptiform discharges 2011 ·Rinsho Shinkeigaku ·Teruaki Masuda, Noriyuki Kimura, Kenichiro Nakamura, Toshio Okazaki, (unknown), Toshihide Kumamoto	4
17	Evaluation of the Regional Cerebral Blood Flow Changes during Long‐Term Donepezil Therapy in Patients with Alzheimer's Disease Using 3DSRT 2011 ·Journal of Neuroimaging ·Noriyuki Kimura, Toshihide Kumamoto, Teruaki Masuda, (unknown), Toshio Okazaki, (unknown)	13
18	Evaluation of the Effects of Thyrotropin Releasing Hormone (TRH) Therapy on Regional Cerebral Blood Flow in the Cerebellar Variant of Multiple System Atrophy Using 3DSRT 2010 ·Journal of Neuroimaging ·Noriyuki Kimura, Toshihide Kumamoto, Teruaki Masuda, Yuki Nomura, (unknown), (unknown), Toshio Okazaki	12
19	A case of Vogt-Koyanagi-Harada disease associated with non-herpetic acute limbic encephalitis with autoantibodies against glutamate receptor .EPSILON.2 in the cerebrospinal fluid 2009 ·Rinsho Shinkeigaku ·Teruaki Masuda, Noriyuki Kimura, (unknown), (unknown), Yukitoshi Takahashi, Toshihide Kumamoto	3
20	Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT 2009 ·Journal of the Neurological Sciences ·Noriyuki Kimura, Toshihide Kumamoto, Teruaki Masuda, Yuki Nomura, (unknown), (unknown), Toshio Okazaki, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact